Activating brain lymphatics to treat craniosynostosis and Alzheimer's disease
Brain lymphatic activation for craniosynostosis and Alzheimer’s disease
This study is looking at how boosting the brain's cleaning system might help people with conditions like craniosynostosis and Alzheimer's disease, using animal models to find new ways to improve brain health and memory.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10884837 on NIH RePORTER |
What this research studies
This research investigates how activating the brain's lymphatic system can help treat conditions like craniosynostosis and Alzheimer's disease. The study focuses on understanding the mechanisms that rejuvenate brain lymphatics, which are crucial for clearing harmful substances from the brain. By using animal models, researchers aim to explore new therapeutic strategies that could improve cognitive functions affected by these conditions. The approach includes innovative techniques such as mesenchymal stem cell-based therapies to enhance lymphatic function.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with craniosynostosis or Alzheimer's disease, particularly those experiencing cognitive impairments.
Not a fit: Patients with other neurological disorders not related to craniosynostosis or Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve cognitive health and quality of life for patients with craniosynostosis and Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in activating brain lymphatics for neurological conditions, suggesting potential for success in this novel approach.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Chen, Jianfu — University of Southern California
- Study coordinator: Chen, Jianfu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.